APPLICATION
ANDA204729
TYPE
ANDA
ORIGINAL APPROVAL
2024-05-01
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
ETODOLACPrescription
ETODOLAC 400MG · TABLET · ORAL
ETODOLACPrescription
ETODOLAC 500MG · TABLET · ORAL
Approval history
2024-11-21Labeling · Supplement 1 · standardAP
2024-05-01UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.